Category: Drug Essentials for Healthcare Professionals
-
Vadadustat Essentials for Healthcare Professionals
What is vadadustat?1 The FDA approved vadadustat (Vafseo®) in March 2024 for the treatment of anemia due to chronic kidney disease (CKD). Vadadustat is only approved for dialysis dependent CKD patients. It is not indicated to replace blood transfusions. What is vadadustat’s mechanism of action? Vadadustat is a hypoxia-inducible factor prolyl hydroxylase (HIF PF) inhibitor.…
-
Fezolinetant Essentials for Healthcare Professionals
Fezolinetant Basics for Patients is available at this link: Fezolinetant Basics for Patients. What is fezolinetant (VeozahTM) and its mechanism of action? Fezolinetant is a neurokinin-3 receptor antagonist.1 The FDA approved it for treating menopausal vasomotor symptoms (aka hot flashes). The antagonism blocks neurokinin B from acting in the brain’s thermoregulatory center.1 This decreases hot…
Dahlia Medical Communications 